Oruka's mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom ...

Continued to advance three clinical programs in immune-mediated diseases: The Phase 3 ONWARD program for ESK-001 in moderate-to-severe plaque psoriasis consists of two ... of risks and uncertainties ...

Lack of compatibility is the top reason for new couples to divorce, with 59% of couples who divorced in their first year citing this cause. A total of 689,308 divorces occurred in 2021 and ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Frailty and functional dependency affect treatment satisfaction and may require tailored care for older adults with psoriasis ...

Study authors examined the use of artificial intelligence in machine learning models for the assessment of psoriasis severity, as well as identified future research needs.

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

A new study aimed to explore the role of stress hyperglycemia ratio (SHR) in predicting mortality risks for patients with ...

The Company submitted an sNDA for ZORYVE foam for scalp and body psoriasis to the FDA based on the positive results from the pivotal ARRECTOR Phase 3 trial and a Phase 2b trial, which was accepted by ...

Psoriasis is a chronic autoimmune skin condition that causes patches of thick, red, scaly skin. Usually, the elbows, knees, ...

Medically reviewed by Casey Gallagher, MD Psoriasis of the hands and feet, known as palmoplantar psoriasis, is an inflammatory autoimmune disorder that causes scaly, itchy skin patches on the palms ...